The Drug Controller General of India renewed Bachem’s license for importing generic active pharmaceutical ingredients (API) to India in August 2013.

This renewal enables us to continue marketing the peptide drug substances calcitonin, goserelin, leuprolide, and somatostatin in India during the upcoming three years. By obtaining the permit, Bachem has additionally safeguarded its API imports to India in terms of compliance.